PDLIM7 Produkte
(PDZ and LIM Domain 7 (Enigma) (PDLIM7))
Kategorien
The protein encoded by this gene is representative of a family of proteins composed of conserved PDZ and LIM domains. LIM domains are proposed to function in protein-protein recognition in a variety of contexts including gene transcription and development and in cytoskeletal interaction. The LIM domains of this protein bind to protein kinases, whereas the PDZ domain binds to actin filaments. The gene product is involved in the assembly of an actin filament-associated complex essential for transmission of ret/ptc2 mitogenic signaling. The biological function is likely to be that of an adapter, with the PDZ domain localizing the LIM-binding proteins to actin filaments of both skeletal muscle and nonmuscle tissues. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte PDLIM7 Kategorien
PDLIM7 Antikörper
High quality antibodies with extensive validation data.
PDLIM7 ELISA Kits
Reliable ELISA kits for a wide range of species.
PDLIM7 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene PDLIM7 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
WB, ELISA, IP, IF, RNAi
Validierungen
- (1)
- (7)
Kat. Nr.
ABIN563997
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human, Mouse, Rat
Applikation
IHC, WB, IF, ICC
Validierungen
- (3)
Kat. Nr.
ABIN6264119
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Epstein-Barr Virus (EBV)
Applikation
IHC (p), IHC (fro)
Validierungen
- (2)
Kat. Nr.
ABIN870474
Menge
7 mL
Datenblatt
Datenblatt
Empfohlene PDLIM7 ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Competition ELISA
Validierungen
Kat. Nr.
ABIN770921
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Guinea Pig
Analytical Method
Quantitative
Validierungen
Kat. Nr.
ABIN777143
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Rabbit
Analytical Method
Quantitative
Validierungen
Kat. Nr.
ABIN775186
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene PDLIM7 Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
Kat. Nr.
ABIN1314572
Menge
10 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Tobacco (Nicotiana tabacum)
Validierungen
- (1)
Kat. Nr.
ABIN3094525
Menge
1 mg
Datenblatt
Datenblatt
Reaktivität
Mouse
Source
Tobacco (Nicotiana tabacum)
Validierungen
- (1)
Kat. Nr.
ABIN3121818
Menge
1 mg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren PDLIM7 Produkten
: "Enigma proteins regulate YAP mechanotransduction." in: Journal of cell science, Vol. 131, Issue 22, (2018) (PubMed).: "The interactome of LIM domain proteins: the contributions of LIM domain proteins to heart failure and heart development." in: Proteomics, Vol. 12, Issue 2, pp. 203-25, (2012) (PubMed).
: "Postsynaptic PDLIM5/Enigma Homolog binds SPAR and causes dendritic spine shrinkage." in: Molecular and cellular neurosciences, Vol. 43, Issue 2, pp. 188-200, (2010) (PubMed).
Synonyme und alternative Namen zu PDLIM7
PDZ and LIM domain 7 (PDLIM7), PDZ and LIM domain 7 (Pdlim7), PDZ and LIM domain 7 S homeolog (pdlim7.S), PDZ and LIM domain 7 (pdlim7), LMP1 (LMP1), 1110003B01Rik, 2410002J21Rik, AV007930, Enigma, enigma, LMP, LMP-1, LMP1, lmp1, LMP3, pdlim7, zgc:65907, zgc:85607Bezeichner auf Proteinebene für PDLIM7
- 1110003B01Rik
- LIM domain protein
- LMP
- Lim mineralization protein 3
- PDZ and LIM domain protein 7
- protein enigma
- enigma protein
- LIM mineralization protein
- LIM mineralization protein 2
- enigma (LIM domain protein)
- LIM mineralizing protein
- ENIGMA
- LMP1
- Protein p63
- hypothetical protein
Sie sind hier:
